| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
56,296,000 |
| Market
Cap: |
244.32(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$2.07 - $5.88 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Sutro Biopharma is a clinical stage drug discovery, development and manufacturing company focused on deploying its proprietary integrated cell-free protein synthesis platform, XpressCF™, to create a variety of protein therapeutics initially for cancer and autoimmune disorders. Co.'s two product candidates are wholly owned: STRO-001, an antibody-drug conjugates (ADC) directed against CD74, for patients with multiple myeloma and non-Hodgkin lymphoma; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
12,185 |
39,226 |
39,226 |
| Total Sell Value |
$0 |
$60,925 |
$186,802 |
$186,802 |
| Total People Sold |
0 |
1 |
2 |
2 |
| Total Sell Transactions |
0 |
1 |
3 |
3 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hallam Trevor |
Pres. Rsrch & Cf. Sctific Ofcr |
• – – |
2022-01-29 |
4 |
D |
$10.39 |
$22,349 |
D/D |
(2,151) |
69,595 |
|
- |
|
| Hallam Trevor |
Pres. Rsrch & Cf. Sctific Ofcr |
• – – |
2022-01-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,250 |
71,746 |
|
- |
|
| Molina Arturo Md |
Chief Medical Officer |
• – – |
2022-01-29 |
4 |
D |
$10.39 |
$22,349 |
D/D |
(2,151) |
29,591 |
|
- |
|
| Molina Arturo Md |
Chief Medical Officer |
• – – |
2022-01-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,250 |
31,742 |
|
- |
|
| Albini Edward C |
CFO and Secretary |
• – – |
2022-01-29 |
4 |
D |
$10.39 |
$22,349 |
D/D |
(2,151) |
21,993 |
|
- |
|
| Albini Edward C |
CFO and Secretary |
• – – |
2022-01-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,250 |
24,144 |
|
- |
|
| Vasquez Nicki |
Chief Port. Strat & Alnce Ofcr |
• – – |
2022-01-29 |
4 |
D |
$10.39 |
$10,639 |
D/D |
(1,024) |
8,746 |
|
- |
|
| Vasquez Nicki |
Chief Port. Strat & Alnce Ofcr |
• – – |
2022-01-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
9,770 |
|
- |
|
| Shabbir Anik |
Chief Technical Ops. Officer |
• – – |
2022-01-29 |
4 |
D |
$10.39 |
$19,159 |
D/D |
(1,844) |
22,209 |
|
- |
|
| Shabbir Anik |
Chief Technical Ops. Officer |
• – – |
2022-01-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,500 |
24,053 |
|
- |
|
| Newell William J |
CEO |
• • – |
2022-01-29 |
4 |
D |
$10.39 |
$54,838 |
D/D |
(5,278) |
101,193 |
|
- |
|
| Newell William J |
CEO |
• • – |
2022-01-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,750 |
106,471 |
|
- |
|
| Fitzpatrick Linda A |
Chief People & Comm. Officer |
• – – |
2022-01-29 |
4 |
D |
$10.39 |
$35,118 |
D/D |
(3,380) |
30,546 |
|
- |
|
| Fitzpatrick Linda A |
Chief People & Comm. Officer |
• – – |
2022-01-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,250 |
33,926 |
|
- |
|
| Newell William J |
CEO |
• • – |
2021-12-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,863 |
106,525 |
|
- |
|
| Newell William J |
CEO |
• • – |
2021-12-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(26,091) |
0 |
|
- |
|
| Vasquez Nicki |
Chief Port. Strat & Alnce Ofcr |
• – – |
2021-09-28 |
4 |
AS |
$18.62 |
$72,724 |
D/D |
(3,906) |
7,270 |
|
-49% |
|
| Vasquez Nicki |
Chief Port. Strat & Alnce Ofcr |
• – – |
2021-09-24 |
4 |
D |
$19.23 |
$39,671 |
D/D |
(2,063) |
11,176 |
|
- |
|
| Vasquez Nicki |
Chief Port. Strat & Alnce Ofcr |
• – – |
2021-09-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,969 |
13,239 |
|
- |
|
| Shabbir Anik |
Chief Technical Ops. Officer |
• – – |
2021-09-24 |
4 |
D |
$19.23 |
$57,228 |
D/D |
(2,976) |
19,553 |
|
- |
|
| Shabbir Anik |
Chief Technical Ops. Officer |
• – – |
2021-09-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,609 |
22,529 |
|
- |
|
| Newell William J |
CEO |
• • – |
2021-09-24 |
4 |
D |
$19.23 |
$254,201 |
D/D |
(13,219) |
92,721 |
|
- |
|
| Newell William J |
CEO |
• • – |
2021-09-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,253 |
105,940 |
|
- |
|
| Albini Edward C |
CFO and Secretary |
• – – |
2021-09-24 |
4 |
D |
$19.23 |
$47,690 |
D/D |
(2,480) |
18,894 |
|
- |
|
| Albini Edward C |
CFO and Secretary |
• – – |
2021-09-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,174 |
21,374 |
|
- |
|
221 Records found
|
|
Page 5 of 9 |
|
|
0.11 (2.6%) 
